Radiometric ear index test as a measure of delayed-type-hypersensitivity in the rat.

PubWeight™: 0.91‹?›

🔗 View Article (PMC 1445392)

Published in Immunology on October 01, 1977

Authors

A A Kostiala

Articles cited by this

STUDIES ON THE SPECIFICITY OF THE CELLULAR INFILTRATE IN DELAYED HYPERSENSITIVITY REACTIONS. J Immunol (1963) 5.37

THE PRODUCTION OF MACROPHAGES IN THE RAT. Br J Exp Pathol (1965) 4.80

Delayed hypersensitivity. III. Specific desensitization of guinea pigs sensitized to protein antigens. J Exp Med (1958) 3.52

Cellular hypersensitivity and immunity. Inhibition of macrophage migration and the lymphocyte mediators. Prog Allergy (1972) 3.47

Radioautographic study of cellular mechanisms in delayed hypersensitivity. I. Delayed reactions to tuberculin and purified proteins in the rat and guinea-pig. Immunology (1963) 2.67

A radioisotopic method to measure delayed type hypersensitivity in the mouse. I. Studies in sensitized and normal mice. Int Arch Allergy Appl Immunol (1975) 2.64

Delayed cutaneous reactions in the rat. J Immunol (1962) 2.60

The mediator of cellular immunity. 3. Lymphocyte traffic from the blood into the inflamed peritoneal cavity. J Exp Med (1971) 2.17

Tularaemia in the rat. I. The cellular basis on host resistance to infection. Immunology (1975) 2.16

Suppression of delayed hypersensitivity by antigen and antibody. Is a common precursor cell responsible for both delayed hypersensitivity and antibody formation? Immunology (1968) 1.99

The measurement of tuberculin hypersensitivity in rats. Int Arch Allergy Appl Immunol (1974) 1.74

Delayed hypersensitivity: bone marrow as the source of cells in delayed skin reactions. Science (1967) 1.35

A radioisotopic method to measure delayed type hypersensitivity in the mouse. II. Cell transfer studies. Int Arch Allergy Appl Immunol (1975) 1.28

Induction of delayed-type hypersensitivity with BCG-associated proteins. Immunology (1976) 1.09

Changes in macrophages in vivo induced by desensitization. Cell Immunol (1976) 1.08

The mediator of cellular immunity. IX. The relationship between cellular hypersensitivity and acquired cellular resistance in rats infected with Listeria monocytogenes. J Exp Med (1975) 1.02

A new method to measure the specific cellular component of a delayed hypersensitivity response in the ear of the mouse. Eur J Immunol (1972) 0.91

Delayed hypersensitivity, macrophage migration, and antibodies in guinea-pigs immunized with diphtheria toxoid. II. Macrophage cytophilic antibody to diphtheria toxoid in desensitized animals. Scand J Immunol (1972) 0.82

Articles by these authors

Tularaemia in the rat. I. The cellular basis on host resistance to infection. Immunology (1975) 2.16

Enzyme-linked immunosorbent assay (ELISA) for IgM, IgG and IgA class antibodies against Candida albicans antigens: development and comparison with other methods. Sabouraudia (1981) 1.09

Fungal arthritis simulating juvenile rheumatoid arthritis. Br Med J (Clin Res Ed) (1982) 1.05

The mediator of cellular immunity. IX. The relationship between cellular hypersensitivity and acquired cellular resistance in rats infected with Listeria monocytogenes. J Exp Med (1975) 1.02

Role of Lymphocytes in Cellular resistance in infection. Contemp Top Immunobiol (1976) 0.99

Use of leucocyte migration under agarose to study spontaneous and directed locomotion of leucocytes. Immunology (1978) 0.96

Immunological memory in tuberculosis. 2. Mediators of protective immunity, delayed hypersensitivity and macrophage migration inhibition in central lymph. Cell Immunol (1978) 0.91

Bacteremia caused by Brevibacterium species in an immunocompromised patient. Eur J Clin Microbiol Infect Dis (1995) 0.90

The mediator of cellular immunity. XI. Origin and development of MIF producing lymphocytes. Cell Immunol (1976) 0.87

Delayed hypersensitivity in the guinea pig immunized with killed tubercle bacilli in adjuvant. 2. The effect of tuberculin purified protein derivative concentration on the inhibition of peritoneal cell migration. Acta Pathol Microbiol Scand B Microbiol Immunol (1971) 0.86

Delayed-type hypersensitivity measured as an increase of ear thickness in guinea pigs. Int Arch Allergy Appl Immunol (1979) 0.84

Delayed hypersensitivity in the guinea pig immunized with killed tubercle bacilli in adjuvant. 1. Development of peritoneal cell migration inhibition, skin reactions and antibodies to tuberculin purified protein derivative. Acta Pathol Microbiol Scand B Microbiol Immunol (1971) 0.83

Levels of C-reactive protein in patients with hematologic malignancies. Scand J Infect Dis (1985) 0.82

Delayed hypersensitivity, macrophage migration, and antibodies in guinea-pigs immunized with diphtheria toxoid. II. Macrophage cytophilic antibody to diphtheria toxoid in desensitized animals. Scand J Immunol (1972) 0.82

Follow-up of antibodies against single-stranded DNA in patients with haematological malignancies. Clin Exp Immunol (1985) 0.81

Serum levels of C-reactive protein in patients with pulmonary tuberculosis and malignant tumors of the chest. Infection (1989) 0.80

Cellular hypersensitivity to tuberculin in BCG-revaccinated persons studied by skin reactivity, leucocyte migration inhibition and lymphocyte proliferation. Clin Exp Immunol (1980) 0.80

Arthritis caused by Haemophilus paraphrophilus and isolation of the organism by using an improved culture protocol. J Clin Microbiol (1987) 0.80

Antibodies against antigens of Candida albicans in patients with fungaemia and bacteraemia, studied by ELISA, precipitation, passive haemagglutination and immunofluorescence techniques. J Med Microbiol (1981) 0.79

Delayed hypersensitivity in the guinea pig immunized with killed tubercle bacilli in adjuvant. 3. Peritoneal cell migration inhibition and macrophage cytophilic antibodies to tuberculin purified protein derivative. Acta Pathol Microbiol Scand B Microbiol Immunol (1972) 0.78

Branhamella catarrhalis as a cause of acute purulent pericarditis. J Infect (1989) 0.77

Dipslide cultures in the investigation of suprapubic urinary bladder aspirates of infants and children. J Clin Pathol (1980) 0.75

Oral mycoses and their treatment. Acta Odontol Scand (1979) 0.75

Pseudomonas aeruginosa infection and vaccination in the rat. J Med Microbiol (1980) 0.75

Immunological classification of a pike lymphoma. Vet Immunol Immunopathol (1986) 0.75

Serial study of C-reactive protein during fungal esophagitis and enterocolitis. Infection (1988) 0.75

Broth dilution and disc diffusion methods in the susceptibility testing of pathogenic Candida albicans against four antimycotics. Mycopathologia (1984) 0.75

Induction of delayed-type hypersensitivity with proteins made insoluble by polymerization. Cell Immunol (1978) 0.75

Effect of nitrofurantoin and methenamine hippurate prophylaxis on bacteria and yeasts in the urine of patients with an indwelling catheter. J Hosp Infect (1982) 0.75

Cutaneous tumor of northern pike, Esox lucius L. II. Expression of surface and cytoplasmic immunoglobulins and alpha-naphthyl acetate esterase by mononuclear cells from lymphoid tissues and tumor. Dev Comp Immunol (1988) 0.75

Immunological and ultrastructural characterization of true histiocytic lymphoma in the northern pike, Esox lucius L. Cancer Res (1990) 0.75

Prospective study on the appearance of antibody-coated bacteria in patients with an indwelling urinary catheter. Nephron (1982) 0.75

Detection of experimental bacteremia and fungemia by examination of buffy coat prepared by a micromethod. Am J Clin Pathol (1979) 0.75

[Ciprofloxacin management of pelvic inflammation caused by Salmonella panama]. Duodecim (1989) 0.75

Susceptibility of fungi in mouthrinse specimens from patients with haematological malignancies. J Med Microbiol (1984) 0.75

Delayed hypersensitivity, macrophage migration, and antibodies in guinea-pigs immunized with diphtheria toxoid. I. Immunization with antigen-antibody precipitation. Scand J Immunol (1972) 0.75

[Oral fungal infections--predisposing conditions and prevention]. Suom Hammaslaakarilehti (1988) 0.75

Prospective study on humoral immune response induced by fungal infection in patients with hematologic malignancies. Infection (1987) 0.75